Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor

PURPOSE: In a previous study, we demonstrated that the combination of fenretinide with lenalidomide, administered by a novel nanomicellar formulation (FLM), provided a strong antitumor effect in a neuroblastoma TrkB-expressing tumor. In this study, we tested the nanomicellar combination in an MYCN a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Nanomedicine
Hlavní autoři: Orienti, Isabella, Farruggia, Giovanna, Nguyen, Ferro, Guan, Peng, Calonghi, Natalia, Kolla, Venkatadri, Chorny, Michael, Brodeur, Garrett M
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7502401/
https://ncbi.nlm.nih.gov/pubmed/32982239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S262032
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky